Exact Mass: 436.2685566

Exact Mass Matches: 436.2685566

Found 168 metabolites which its exact mass value is equals to given mass value 436.2685566, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DHAP(18:0)

1-Octadecanoyl Dihydroxyacetone phosphate;1-stearoylglycerone 3-phosphate

C21H41O7P (436.25897660000004)


DHAP(18:0) is the octadecanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. [HMDB] DHAP(18:0) is the octadecanoyl derivative of dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. (Wikipedia)

   

LysoPA(18:1(9Z)/0:0)

9-Octadecenoic acid (9Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester

C21H41O7P (436.25897660000004)


LysoPA(18:1(9Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

Pangamic acid

6-({2,2-bis[bis(propan-2-yl)amino]acetyl}oxy)-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


Pangamic acid is found in apricot. Pangamic acid is isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control Pangamic acid is also known as vitamin B15, but it is not widely accepted as a vitamin for it has not been shown to be essential in the human diet, and a deficiency in consumption of pangamic acid is not known to be associated with any disease. Pangamic acid is an ester derived from gluconic acid and dimethylglycine. It was first isolated by Ernst T. Krebs from apricot kernels, and has since been identified in some foods such as pulses. Also found in rice bran & apricot kernels Isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control

   

LysoPA(0:0/18:1(9Z))

{3-hydroxy-2-[(9Z)-octadec-9-enoyloxy]propoxy}phosphonic acid

C21H41O7P (436.25897660000004)


LysoPA(0:0/18:1(9Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

3-{[3-hydroxy-4-(hydroxymethyl)-4-methyloxolan-2-yl]oxy}-6-(hydroxymethyl)-2-[(3-hydroxyoctyl)oxy]-5-methyloxan-4-ol

C21H40O9 (436.26721900000007)


(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is a constituent of calabash tree (Crescentia cujete) fruits. Constituent of calabash tree (Crescentia cujete) fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits.

   

(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate

9-Octadecenoic acid (9Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester

C21H41O7P (436.25897660000004)


   

20-Hydroxytingenone

20-Hydroxytingenone

C28H36O4 (436.2613456)


   

Azadirone

Azadirone

C28H36O4 (436.2613456)


A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by an oxo group at position 3, an acetoxy group at position 7 and a furan-3-yl group at position 17. Isolated from Azadirachta indica, it exhibits antiplasmodial and antineoplastic activities.

   
   
   
   

22beta-Hydroxymaytenin

22beta-Hydroxymaytenin

C28H36O4 (436.2613456)


   
   
   
   

glyceryl mono-oleolyl-2-phosphate

glyceryl mono-oleolyl-2-phosphate

C21H41O7P (436.25897660000004)


   
   

2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|6-oxotingenol

2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|6-oxotingenol

C28H36O4 (436.2613456)


   
   

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|4,17-dihydro 17 alpha-tchibangensine

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|4,17-dihydro 17 alpha-tchibangensine

C29H32N4 (436.26268319999997)


   

(22R)-4beta-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide

(22R)-4beta-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide

C28H36O4 (436.2613456)


   
   

15-alpha-hydroxytingenone

15-alpha-hydroxytingenone

C28H36O4 (436.2613456)


   

3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-23-hydroxyergosta-4,6,8,11-tetraen-3-one|blazeispirol U

(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-23-hydroxyergosta-4,6,8,11-tetraen-3-one|blazeispirol U

C28H36O4 (436.2613456)


   
   
   
   

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-16-nor-coryn-3(14)-ene|3-Dehydrochrolifuanin|3-Dehydroochrolifuanin

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-16-nor-coryn-3(14)-ene|3-Dehydrochrolifuanin|3-Dehydroochrolifuanin

C29H32N4 (436.26268319999997)


   
   
   
   
   
   
   

Withasomniferolide A

Withasomniferolide A

C28H36O4 (436.2613456)


   

Withasomniferolide B

Withasomniferolide B

C28H36O4 (436.2613456)


   
   

PA(18:1/0:0)

9-Octadecenoic acid (Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C21H41O7P (436.25897660000004)


   

Oleoyl lysophosphatidic acid

1-(9Z-octadecenoyl)-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


   

(5Z,7E)-(1S,3R)-24-methylsulfonyl-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-24-methylsulfonyl-25,26,27-trinorvitamin D3 / 1α-hydroxy-24-methylsulfonyl-25,26,27-trinorcholecalciferol

C25H40O4S (436.2647160000001)


   

LysoPA(18:1)

2-(9Z-octadecenoyl)-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


   

1-Oleoyl Lysophosphatidic Acid (sodium salt)

1-O-9Z-octadecenoyl-sn-glyceryl-3-phosphoric acid, sodium salt

C21H41O7P (436.25897660000004)


   

Vitamin B15

6-({2,2-bis[bis(propan-2-yl)amino]acetyl}oxy)-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

3-{[3-hydroxy-4-(hydroxymethyl)-4-methyloxolan-2-yl]oxy}-6-(hydroxymethyl)-2-[(3-hydroxyoctyl)oxy]-5-methyloxan-4-ol

C21H40O9 (436.26721900000007)


   

LPA 18:1

9-Octadecenoic acid (Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C21H41O7P (436.25897660000004)


   

ST 28:6;O3

(22R)-3,26-Dioxo-22,26-epoxyergosta-1,4,24-trien-18-al

C28H36O4 (436.2613456)


   

1alpha-hydroxy-24-methylsulfonyl-25,26,27-trinorvitamin D3

(5Z,7E)-(1S,3R)-24-methylsulfonyl-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C25H40O4S (436.2647160000001)


   

Lifarizine

Lifarizine

C29H32N4 (436.26268319999997)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker

   

Cipemastat

Cipemastat

C22H36N4O5 (436.2685566)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   
   

Dimethyl-amino-acetylgluconic acid

Dimethyl-amino-acetylgluconic acid

C20H40N2O8 (436.278452)


   

pangamic acid

(2R,3S,4R,5R)-6-[2,2-bis(di(propan-2-yl)amino)ethanoyloxy]-2,3,4,5-tetrahydroxy-hexanoic acid

C20H40N2O8 (436.278452)


   

1-Stearoyl-sn-glycero-3-phosphate(2-)

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.25897660000004)


   
   

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C21H41O7P (436.25897660000004)


   

[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-11-enoate

[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-11-enoate

C21H41O7P (436.25897660000004)


   

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.25897660000004)


   

6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one

6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one

C24H32N6O2 (436.25866119999995)


   

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   
   
   
   

[(E)-2-(hexanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-acetamido-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-(butanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   
   

1-Oleoyl-sn-glycerol 3-phosphate

1-Oleoyl-sn-glycerol 3-phosphate

C21H41O7P (436.25897660000004)


A 1-acyl-sn-glycerol 3-phosphate having oleoyl as the 1-O-acyl group.

   

1-Stearoyl-sn-glycero-3-phosphate(2-)

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.25897660000004)


A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-stearoyl-sn-glycero-3-phosphate.

   
   

2-hydroxy-3-(phosphonooxy)propyl octadec-9-enoate

2-hydroxy-3-(phosphonooxy)propyl octadec-9-enoate

C21H41O7P (436.25897660000004)


   

6-[2,2-Bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

6-[2,2-Bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

Paraminabeolide A

Paraminabeolide A

C28H36O4 (436.2613456)


A withanolide that is 22,26-epoxyergosta-1,4,24-triene-18-al substituted by oxo groups at positions 3 and 26. Isolated from a Formosan soft coral, Paraminabea acronocephala, it exhibits cytotoxic activity.

   

2-oleoyl-sn-glycero-3-phosphate

2-oleoyl-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as oleoyl.

   

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.25897660000004)


A 1-alkyl-2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmityl-2-acetyl-sn-glycero-3-phosphate; major species at pH 7.3.

   
   

1-octadec-9-enoylglycero-3-phosphate

1-octadec-9-enoylglycero-3-phosphate

C21H41O7P (436.25897660000004)


   

LPEt(16:1)

LPEt(16:1)

C21H41O7P (436.25897660000004)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 10:3/O-18:6

FAHFA 10:3/O-18:6

C28H36O4 (436.2613456)


   

FAHFA 12:4/O-16:5

FAHFA 12:4/O-16:5

C28H36O4 (436.2613456)


   

FAHFA 13:4/O-15:5

FAHFA 13:4/O-15:5

C28H36O4 (436.2613456)


   

FAHFA 15:5/O-13:4

FAHFA 15:5/O-13:4

C28H36O4 (436.2613456)


   

FAHFA 16:5/O-12:4

FAHFA 16:5/O-12:4

C28H36O4 (436.2613456)


   

FAHFA 18:6/O-10:3

FAHFA 18:6/O-10:3

C28H36O4 (436.2613456)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(1s,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1s,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)


   

(2r,3s,4r,5r)-6-{[2,2-bis(diisopropylamino)acetyl]oxy}-2,3,4,5-tetrahydroxyhexanoic acid

(2r,3s,4r,5r)-6-{[2,2-bis(diisopropylamino)acetyl]oxy}-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

2,3-dimethoxy-5-methyl-6-[(2e,6z,9e)-3,7,9-trimethyl-11-phenylundeca-2,6,9-trien-1-yl]pyran-4-one

2,3-dimethoxy-5-methyl-6-[(2e,6z,9e)-3,7,9-trimethyl-11-phenylundeca-2,6,9-trien-1-yl]pyran-4-one

C28H36O4 (436.2613456)


   

(1'r,2s,3r,4s,10's,14'r,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

(1'r,2s,3r,4s,10's,14'r,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613456)


   

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(1r,5s,7r)-7-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5s,7r)-7-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(1r,3bs,4r,5ar,9as,9bs,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3bs,4r,5ar,9as,9bs,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)


   

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-11-ethoxy-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-11-ethoxy-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C28H36O4 (436.2613456)


   

(6bs,7s,8as,11r,12ar,12bs,14as)-3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

(6bs,7s,8as,11r,12ar,12bs,14as)-3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

(8ar,9s,10r,11s,12as,12bs,14as)-3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

(8ar,9s,10r,11s,12as,12bs,14as)-3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

C28H36O4 (436.2613456)


   

6-oxotingenol

NA

C28H36O4 (436.2613456)


{"Ingredient_id": "HBIN012741","Ingredient_name": "6-oxotingenol","Alias": "NA","Ingredient_formula": "C28H36O4","Ingredient_Smile": "CC1CC2C(CCC3(C2(CCC4(C3=CC(=O)C5=C(C(=C(C=C54)O)O)C)C)C)C)(CC1=O)C","Ingredient_weight": "436.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16418","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10410773","DrugBank_id": "NA"}

   

(1'r,2s,3r,4s,10's,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

(1'r,2s,3r,4s,10's,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613456)


   

(2e)-n-[(3s,7r,10r)-2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl]-6-methylhept-2-enimidic acid

(2e)-n-[(3s,7r,10r)-2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl]-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2685566)


   

(1r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(2s,3e,12bs)-3-ethylidene-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3e,12bs)-3-ethylidene-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

3-ethylidene-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

3-ethylidene-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

3-ethenyl-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

3-ethenyl-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

7-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

7-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(6bs,8ar,9s,11r,12as,12bs,14ar)-3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

(6bs,8ar,9s,11r,12as,12bs,14ar)-3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

(1'r,2s,3r,4s,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

(1'r,2s,3r,4s,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613456)


   

(6ar,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

(6ar,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613456)


   

methyl (1r,4s,5r,9s,10s,13r,15s)-15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl (1r,4s,5r,9s,10s,13r,15s)-15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C28H36O4 (436.2613456)


   

(2s,3r,12bs)-3-ethenyl-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3r,12bs)-3-ethenyl-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

(6as,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

(6as,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613456)


   

(3ar,7r,7as)-6-[(3ar,9r,9as)-9-hydroxy-2,2,9-trimethyl-4-oxo-1h,3h,3ah,9ah-cyclopenta[b]naphthalen-6-yl]-7-hydroxy-2,2,7-trimethyl-1,3,3a,7a-tetrahydroinden-4-one

(3ar,7r,7as)-6-[(3ar,9r,9as)-9-hydroxy-2,2,9-trimethyl-4-oxo-1h,3h,3ah,9ah-cyclopenta[b]naphthalen-6-yl]-7-hydroxy-2,2,7-trimethyl-1,3,3a,7a-tetrahydroinden-4-one

C28H36O4 (436.2613456)


   

methyl 15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl 15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C28H36O4 (436.2613456)


   

2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613456)


   

3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

(1r,2r,10r,11s,14r,15r,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

(1r,2r,10r,11s,14r,15r,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

C28H36O4 (436.2613456)


   

(6bs,8as,11s,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

(6bs,8as,11s,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613456)


   

(14z,17z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),14,17,24,27-octaene-5,26,27-triol

(14z,17z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),14,17,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613456)


   

(6bs,8as,11r,12ar,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

(6bs,8as,11r,12ar,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613456)


   

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O4 (436.2613456)


   

3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

(13z,16z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

(13z,16z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613456)


   

(2r,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,7ah,12h,12ah,12bh-indolo[2,3-a]quinolizine

(2r,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,7ah,12h,12ah,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

(2s)-2-hydroxy-3-[(9z)-octadec-9-enoyloxy]propoxyphosphonic acid

(2s)-2-hydroxy-3-[(9z)-octadec-9-enoyloxy]propoxyphosphonic acid

C21H41O7P (436.25897660000004)


   

(2e)-n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

(2e)-n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2685566)


   

n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2685566)


   

(13z,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

(13z,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613456)


   

3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

C28H36O4 (436.2613456)


   

8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(1s,5s)-8-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1s,5s)-8-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613456)


   

(13e,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

(13e,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613456)


   

(2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

(2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O4 (436.2613456)


   

(4e,6r)-6-[(1r,9ar,9br,11ar)-9a,11a-dimethyl-4,6-dioxo-1h,2h,3h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethylhept-4-enoic acid

(4e,6r)-6-[(1r,9ar,9br,11ar)-9a,11a-dimethyl-4,6-dioxo-1h,2h,3h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethylhept-4-enoic acid

C28H36O4 (436.2613456)


   

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613456)


   

(6r)-6-[(1s)-1-[(3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

(6r)-6-[(1s)-1-[(3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O4 (436.2613456)


   

(2s,3e,12bs)-3-ethylidene-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3e,12bs)-3-ethylidene-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.26268319999997)


   

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

C28H36O4 (436.2613456)


   

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)


   

(6bs,8as,11r,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

(6bs,8as,11r,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613456)


   

6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O4 (436.2613456)


   

3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613456)


   

(1r,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)